Researchers discover a new, fast, and precise method for detecting COVID-19 and breast cancer indicators in blood samples. We may be able to use a simple blood test to diagnose diseases using tiny nanopores and nanobodies.
The study was published in Journal, 'ACS Nano.'
While some individuals are able to recover from the consequences of SARS-CoV-2 infection, others have continued to endure COVID-19 aftereffects for a very long time. The inability to exercise as much is one of these persistent COVID symptoms. But there are still unanswered issues about the r
A team of researchers developed an electronic biosensor based on DNA aptamers that can detect biomarkers in whole blood samples without the use of reagents.
An electronic biosensor based on DNA aptamers developed by a team of researchers can detect biomarkers in whole blood samples without the use of reagents. DNA aptamers recognise marker proteins as well as antibodies, but they are simpler to prepare and more adaptable. Without any additional
Early identification and treatment of Alzheimer's disease need the use of trustworthy and cost-effective screening technology. Researchers at Sweden's Karolinska Institutet discovered that the quantity of tau, a protein that plays an important role in the development of severe dementia, is l
At the European Conference of Clinical Microbiology & Infectious Diseases (ECCMID) this year in Copenhagen, Denmark, data on a test that may detect HIV, hepatitis B, and hepatitis C from a single drop of blood are being presented.
Early detection and treatment of Alzheimer's disease require the use of dependable and cost-effective screening technologies. Researchers at Sweden's Karolinska Institutet have revealed that the level of tau, a protein that plays a vital role in the development of severe dementia, is associa
Researchers discovered disrupted amounts of chemical components in maternal blood and cord blood linked to later diagnosis of autism spectrum disorder in a new study (ASD).
The University of Technology Sydney researchers have created a novel tool that enables doctors to skip invasive biopsy operations and to track the effectiveness of treatment by detecting and analysing cancer cells from blood samples.
Researchers from the University of Technology Sydney have created a novel tool that enables doctors to skip invasive biopsy operations and to track the effectiveness of treatment by detecting and analysing cancer cells from blood samples.